Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women.

[1]  Dongmin Liu,et al.  Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. , 2006, Diabetes.

[2]  J. Després,et al.  Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. , 2006, Journal of endocrinological investigation.

[3]  M. J. Toth,et al.  The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. , 2006, The Journal of clinical endocrinology and metabolism.

[4]  D. Grobbee,et al.  Soy isoflavones, body composition, and physical performance. , 2005, Maturitas.

[5]  V. Positano,et al.  Visceral fat and beta cell function in non-diabetic humans , 2005, Diabetologia.

[6]  T. Pennimpede,et al.  The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. , 2004, Endocrinology.

[7]  R. DeFronzo,et al.  A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. , 2003, Diabetes.

[8]  B. Geloneze,et al.  Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double‐blind, randomized, placebo‐controlled trial , 2003, Diabetes, obesity & metabolism.

[9]  D. Lubahn,et al.  The soy isoflavone genistein decreases adipose deposition in mice. , 2003, Endocrinology.

[10]  D. Alekel,et al.  Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal women , 2003, Menopause.

[11]  P. Delamarche,et al.  Estrogen receptor alpha mRNA in human skeletal muscles. , 2003, Medicine and science in sports and exercise.

[12]  M. Velasquez,et al.  Beneficial role of dietary phytoestrogens in obesity and diabetes. , 2002, The American journal of clinical nutrition.

[13]  E. Kilpatrick,et al.  Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. , 2002, Diabetes care.

[14]  J. Gerich,et al.  Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? , 2002, Diabetes.

[15]  S. Kumar,et al.  Site‐specific regulation of oestrogen receptor‐α and ‐β by oestradiol in human adipose tissue , 2001 .

[16]  D. Kritz-Silverstein,et al.  Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. , 2001, The Journal of nutrition.

[17]  S. Tsai,et al.  The impact of years since menopause on the development of impaired glucose tolerance. , 2001, Journal of clinical epidemiology.

[18]  A. Barnett,et al.  Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. , 2001, Diabetes, obesity & metabolism.

[19]  M. J. Toth,et al.  Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. , 2000, Diabetes care.

[20]  Y. Matsuzawa,et al.  Estrogen Suppresses Transcription of Lipoprotein Lipase Gene , 2000, The Journal of Biological Chemistry.

[21]  E. Poehlman,et al.  Effect of menopausal status on body composition and abdominal fat distribution , 2000, International Journal of Obesity.

[22]  A. Duncan,et al.  Modest hormonal effects of soy isoflavones in postmenopausal women. , 1999, The Journal of clinical endocrinology and metabolism.

[23]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[24]  T. León‐Quinto,et al.  Rapid insulinotropic effect of 17β‐estradiol via a plasma membrane receptor , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  W. Cefalu,et al.  Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. , 1997, Metabolism: clinical and experimental.

[26]  H. Fukuda,et al.  Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. , 1997, The Journal of nutrition.

[27]  S. B. Pedersen,et al.  Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue , 1996, European journal of clinical investigation.

[28]  S. Barnes,et al.  Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[29]  C. Christiansen,et al.  Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. , 1995, Metabolism: clinical and experimental.

[30]  I. Godsland,et al.  The effects of the menopause on insulin sensitivity, secretion and elimination in non‐obese, healthy women , 1993, European journal of clinical investigation.

[31]  B. Lees,et al.  Sex- and menopause-associated changes in body-fat distribution. , 1992, The American journal of clinical nutrition.

[32]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[33]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.